verapamil and 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid

verapamil has been researched along with 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cóte, D; Ksander, G; Levens, NR	1

Other Studies

1 other study(ies) available for verapamil and 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid

Article	Year
Inhibition of thromboxane synthetase potentiates the antihypertensive action of an angiotensin-converting enzyme inhibitor by a prostaglandin-dependent but kinin-independent mechanism. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:1 Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Drug Synergism; Indomethacin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin; Species Specificity; Thromboxane-A Synthase; Verapamil	1991

Article

Year

Inhibition of thromboxane synthetase potentiates the antihypertensive action of an angiotensin-converting enzyme inhibitor by a prostaglandin-dependent but kinin-independent mechanism.

The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:1

Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Drug Synergism; Indomethacin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin; Species Specificity; Thromboxane-A Synthase; Verapamil

1991